Press Releases

07.11.2019 | Nanion and Assay.Works Partner to offer Drug Discovery Services for Membrane Transporter Targets

Munich, Germany, November 7th 2019: Nanion Technologies, a leading provider of automated electrophysiology systems, today announced its partnership with Assay.Works, experts in assay development and High Throughput Screening (HTS), who will be providing SURFE²R 96SE assays “As-a-Service” for membrane transporter research.
Membrane transport proteins, enabling active and secondary active transport of ions and solutes across the membrane, are important drug targets but may also be involved in unwanted side effects of novel drug candidates. As response to the growing demand in assay options for membrane transporters and to afford researchers access to SSM-based electrophysiology, Nanion and Assay.Works have entered into a partnership.

Read the full press release here.

Back to Overview

 

New Genedata Screener®APC Functionality and Integration with Nanion SyncroPatch 384PE at SLAS2017
Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
More information Ok